Skip Navigation LinksHome > April 2013 - Volume 32 - Issue 4 > Benefit of Conjugate Pneumococcal Vaccination in Preventing...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e318280a34b
Original Studies

Benefit of Conjugate Pneumococcal Vaccination in Preventing Influenza Hospitalization in Children: A Case-control Study

Domínguez, Angela MD, PhD*†; Castilla, Jesús MD, PhD†‡; Godoy, Pere MD, PhD†§; Delgado-Rodríguez, Miguel MD, PhD†¶; Saez, Marc BSc, PhD†‖; Soldevila, Núria BSc; Astray, Jenaro MD, MSc**; María Mayoral, José MD, PhD††; Martín, Vicente MD, PhD† ‡‡; María Quintana, José MD, PhD† §§; González-Candelas, Fernando BSc, PhD† ¶¶; Galán, Juan Carlos BSc, PhD† ‖‖; Tamames, Sonia MD, PhD***; Acosta, Ady Castro MD†††; Baricot, Maretva BSc, PhD; Garín, Olatz MPH† ‡‡‡; José García, Juan MD, PhD§§§; Moraga, Fernando MD¶¶¶; Pumarola, Tomás MD, PhD‖‖‖; for the CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain

Supplemental Author Material
Collapse Box


Background: The pneumococcal conjugate vaccine (PCV) might prevent hospitalizations in children because of the role of Streptococcus pneumoniae in the complications of influenza infection. We investigated the benefit of PCV vaccination in preventing influenza hospitalization in children <5 years of age during the 2009 to 2010 pandemic wave and the 2010 to 2011 influenza epidemic in Spain.

Methods: A multicenter matched case-control study was undertaken in 27 hospitals from 7 Spanish regions between July 2009 and April 2011. A case was defined as a hospitalized patient between 6 months and 5 years of age with influenza virus infection confirmed by real-time reverse-transcription polymerase chain reaction. We selected 2 matched controls for each case from patients with unplanned hospital admission for reasons other than acute respiratory infection or influenza-like illness. Cases and controls were matched according to age, date of hospitalization and province of residence. Crude and adjusted odds ratios were calculated for associations between influenza hospitalization and PCV vaccination.

Results: One hundred ninety-four cases and 342 controls were included in the study. In the 2009 to 2010 pandemic wave, the adjusted benefit in preventing hospitalization was 48% (95% confidence interval: 1 to 76) in fully vaccinated children compared with –79% (95% confidence interval: –341 to 27) in the 2010 to 2011 influenza season.

Conclusions: The results obtained suggest that, in children <5 years of age, PCV vaccination reduced hospitalization during the 2009 to 2010 pandemic wave. By contrast, there was no observed benefit of vaccination in the 2010 to 2011 influenza season.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.